262 related articles for article (PubMed ID: 22708516)
1. Protein arginine methyltransferase 5 is essential for growth of lung cancer cells.
Gu Z; Gao S; Zhang F; Wang Z; Ma W; Davis RE; Wang Z
Biochem J; 2012 Sep; 446(2):235-41. PubMed ID: 22708516
[TBL] [Abstract][Full Text] [Related]
2. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
[TBL] [Abstract][Full Text] [Related]
3. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
4. Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth.
Zhang S; Ma Y; Hu X; Zheng Y; Chen X
J Cell Mol Med; 2019 Feb; 23(2):1333-1342. PubMed ID: 30461193
[TBL] [Abstract][Full Text] [Related]
5. Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation.
Sheng X; Wang Z
BMC Cancer; 2016 Aug; 16():567. PubMed ID: 27480244
[TBL] [Abstract][Full Text] [Related]
6. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract][Full Text] [Related]
7. Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells.
Zakrzewicz D; Didiasova M; Krüger M; Giaimo BD; Borggrefe T; Mieth M; Hocke AC; Zakrzewicz A; Schaefer L; Preissner KT; Wygrecka M
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1816-1827. PubMed ID: 29501774
[TBL] [Abstract][Full Text] [Related]
8. PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis.
Zheng Y; Lu J; Hu X; Hu X; Gao X; Zhou J
Technol Cancer Res Treat; 2023; 22():15330338231161139. PubMed ID: 36927233
[No Abstract] [Full Text] [Related]
9. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth.
Liu L; Yan H; Ruan M; Yang H; Wang L; Lei B; Sun X; Chang C; Huang G; Xie W
Cancer Sci; 2021 Aug; 112(8):3083-3098. PubMed ID: 34033176
[TBL] [Abstract][Full Text] [Related]
10. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.
Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y
J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651
[TBL] [Abstract][Full Text] [Related]
11. GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.
Sheng X; Bowen N; Wang Z
Mol Cancer; 2016 Mar; 15():25. PubMed ID: 26988096
[TBL] [Abstract][Full Text] [Related]
12. Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors.
Shilo K; Wu X; Sharma S; Welliver M; Duan W; Villalona-Calero M; Fukuoka J; Sif S; Baiocchi R; Hitchcock CL; Zhao W; Otterson GA
Diagn Pathol; 2013 Dec; 8():201. PubMed ID: 24326178
[TBL] [Abstract][Full Text] [Related]
13. PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells.
Bajbouj K; Ramakrishnan RK; Saber-Ayad M; Omar HA; Saheb Sharif-Askari N; Shafarin J; Elmoselhi AB; Ihmaid A; AlHaj Ali S; Alalool A; Abdullah R; Hamid Q
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200178
[TBL] [Abstract][Full Text] [Related]
14. Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.
Zhang B; Zhang S; Zhu L; Chen X; Zhao Y; Chao L; Zhou J; Wang X; Zhang X; Ma N
Toxicol Appl Pharmacol; 2017 Dec; 336():1-7. PubMed ID: 28987382
[TBL] [Abstract][Full Text] [Related]
15. Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.
Ibrahim R; Matsubara D; Osman W; Morikawa T; Goto A; Morita S; Ishikawa S; Aburatani H; Takai D; Nakajima J; Fukayama M; Niki T; Murakami Y
Hum Pathol; 2014 Jul; 45(7):1397-405. PubMed ID: 24775604
[TBL] [Abstract][Full Text] [Related]
16. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.
Yan F; Alinari L; Lustberg ME; Martin LK; Cordero-Nieves HM; Banasavadi-Siddegowda Y; Virk S; Barnholtz-Sloan J; Bell EH; Wojton J; Jacob NK; Chakravarti A; Nowicki MO; Wu X; Lapalombella R; Datta J; Yu B; Gordon K; Haseley A; Patton JT; Smith PL; Ryu J; Zhang X; Mo X; Marcucci G; Nuovo G; Kwon CH; Byrd JC; Chiocca EA; Li C; Sif S; Jacob S; Lawler S; Kaur B; Baiocchi RA
Cancer Res; 2014 Mar; 74(6):1752-65. PubMed ID: 24453002
[TBL] [Abstract][Full Text] [Related]
17. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade.
Wei TY; Juan CC; Hisa JY; Su LJ; Lee YC; Chou HY; Chen JM; Wu YC; Chiu SC; Hsu CP; Liu KL; Yu CT
Cancer Sci; 2012 Sep; 103(9):1640-50. PubMed ID: 22726390
[TBL] [Abstract][Full Text] [Related]
18. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
19. PRMT5 Promotes EMT Through Regulating Akt Activity in Human Lung Cancer.
Huang J; Zheng Y; Zheng X; Qian B; Yin Q; Lu J; Lei H
Cell Transplant; 2021; 30():9636897211001772. PubMed ID: 33829865
[TBL] [Abstract][Full Text] [Related]
20. Protein N-arginine methyltransferase 5 promotes the tumor progression and radioresistance of nasopharyngeal carcinoma.
Yang D; Liang T; Gu Y; Zhao Y; Shi Y; Zuo X; Cao Q; Yang Y; Kan Q
Oncol Rep; 2016 Mar; 35(3):1703-10. PubMed ID: 26708443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]